Vitamins China E-News

Publication: Monthly on the
Published by CCM

Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
 
China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
 
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
  •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
  •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
  •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.


  • Future-issues subscription

Starting from the issue of
202403
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950
  • Corporate license:
    USD 7,375

All the prices on this website exclude VAT.

<<
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
>>

Main Content of Vitamins China E-News 202108

Price of this issue :
USD 148

Published on 31st August, 2021

This month, the Chinese vitamin market has not been buoyant as expected, even with favorable factors. Sellers offered high quoted prices under few downstream inquiries, and various vitamin varieties saw mild price fluctuations.

Published on 31st August, 2021

In H1, export volume and export value of vitamins in China rose by 1.19% and 3.48% YoY respectively.

Published on 31st August, 2021

In 21-29 July, checking and approval results of Royal Federation's project of 100 t/a vitamin premix, 50 t/a dustablepowder for animal use, 600 t/a granule for animal use and 800 t/a oral liquid for animal use were released.

Published on 30th August, 2021

Two NMN projects passed EIA — Yikelai Pharmaceutical's technology upgrading project of 100 t/a sitagliptin, 100 t/a nicotinamide mononucleotide (NMN) and 90 t/a 2-R-BOC-butyric acid, and Kangjie Biotechnology's expansion project of 20 t/a NMN and 60 t/a DHA algal oil.

Published on 30th August, 2021

Published on 30th August, 2021

On 5 Aug., Huarui Bio publicised an EIA report of its Bio-Pharmaceutical Project (Phase II) on the homepage of the People's Government of Nehe City, Qiqihar City, Heilongjiang Province, planned to produce cyanocobalamin (vitamin B12) feed additive and other products.

Published on 30th August, 2021

Domestic paricalcitol injection manufacturers are proactively promoting the consistency evaluation of generic drugs. Chengdu Easton Biopharmaceuticals is the 2nd pharmaceutical company, only following Jiangsu Hengrui Pharmaceuticals, that has passed such evaluation of paricalcitol injections in China.

Published on 24th August, 2021

On 27 July, the National Medical Products Administration (NMPA) announced its decision to revise the Adverse Reactions and Contraindications in the package insert of vitamin B6 injection.

Published on 20th August, 2021

Tianxin Pharmaceutical's VA, VB5, cholesterol and 25-hydroxyvitamin D3 project was on the list of "New Projects to be Under Construction of Jingde City in Jiangxi Province in July 2021". Most funds for the project were from IPO of Tianxin Pharmaceutical.

Published on 20th August, 2021

:On 2 Aug., GBG went public on Shanghai Stock Exchange. The company's IPO was for nine sub-projects, including a newly-built preparation for animal health project of Hebao Biotechnology.

Published on 18th August, 2021

Published on 18th August, 2021

Published on 18th August, 2021

Published on 16th August, 2021

Published on 16th August, 2021

Published on 11th August, 2021

Published on 9th August, 2021

Published on 5th August, 2021

Published on 5th August, 2021

Published on 5th August, 2021

On 31 July, Garden Biochemical posted its performance report in H1 2021, suggesting an increase in operating revenue by 1.29% and net profit attributable to shareholders of listed companies by 44.94%.

Published on 4th August, 2021

Published on 4th August, 2021

Published on 3rd August, 2021


CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement